The Importance of Efficacy and Partial Agonism in Evaluating Models of B Lymphocyte Activation

Abstract

Immunologists have developed a range of in vitro techniques for probing the receptor mediated response of cells comprising the immune system. An important and ubiquitous method is the use of antibodies in either soluble or aggregated form to engage cell surface receptors and transmit a signal. Models of cell and molecular interactions, derived from the use of these antibodies, form the basis of our efforts to understand and explain the corresponding in vivo systems. However, interpreting in vitro experiments and distinguishing between alternative models is difficult. This complexity is illustrated here using B cell stimulation by surface immunoglobulin and CD40. The fluorescent cell labelling dye carboxyfluorescein, diacetate, succinimidyl ester (CFSE) is used to show that many anti-Ig and CD40 stimulatory agents, used to assess the role of B cells and lymphokines, are partial agonists. By modelling each step in B cell signalling, activation and division it is possible to show that small changes in signal contributed by a second receptor can generate numerous distinct dose response curves that are highly dependent on the "efficacy" of signal transmission by the primary ligand and the number of cell divisions taken in culture. Differences in dose response curves become particularly striking if the primary activating stimulus is a partial agonist. Although exemplified here with B cell stimulation the conclusions are applicable to other in vitro activation systems and suggest ways to improve both the design and interpretation of in vitro experiments.*Corresponding author. Tel.: 61 2 9565 6121. Fax: 61 2 9565 5103.

Loss of adenomatous polyposis coli gene function disrupts thymic development

“…Sorted DN4 thymocytes were labeled with CFSE using a modification of a published method 50 . Sorted cells (1 × 10 6 to 1.5 × 10 6 ) were resuspended in 200 μl PBS supplemented with 0.1% BSA and 5 μM CFSE.…”

The protooncogeneMYCcan break B cell tolerance

“…In those experiments, activated B cells that had been retrovirally transduced with GFP-expressing retroviruses were labeled with a final concentration of 10 nM BODIPY red, as described (22). We also measured B cell proliferation as determined by the incorporation of [ 3 H]thymidine, as described (18).…”

“…The nonadherent cells were washed twice and used as the source of B cells. Cells were labeled with 5-(and 6-)-carboxyfluorescein diacetate, succinimyl ester (CFSE) (Molecular Probes), as described (21,22).…”

“…It occurred to us that the effect of MYC on tolerance might involve the role of cytokines in B cell function. B cell anergy can be overcome by the addition of high doses of cytokines in vitro (3), or by T cell help in vivo (21,22,27). Mindful of prior evidence that MYC could act as an important effector of cytokines (28), we reasoned that the overexpression of MYC might serve as a surrogate signal in the breach of B cell tolerance.…”

Antibody Production and In Vitro Behavior of CD27-Defined B-Cell Subsets: Persistent Hepatitis C Virus Infection Changes the Rules

“…In humans, this exploration is confined to in vitro models in which combinations of surrogate signals mimic the range of physiological stimulations that may occur in vivo (12,27). Most of these signals are relatively well understood.…”